ARCUS
Live / Registered — Registered and renewed (as of 11 Apr 2023)
What this means for you
Registered since 02 Oct 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Oct 2022).
Record
- Serial number
- 85529823
- Registration number
- 4217046
- Mark type
- Stylized text
- Filed
- 31 Jan 2012
- Published for opposition
- 17 Jul 2012
- Registered
- 02 Oct 2012
- Next maintenance due
- 02 Oct 2022
- Attorney of record
- Joseph C. Guagliardo
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services, namely, the development of drug delivery devices and pharmaceutical products to the pulmonary system
Owner
- MERZ PHARMACEUTICALS, LLC, RALEIGH, NC, US
- ACORDA THERAPEUTICS, INC., Ardsley, NY, US
- Civitas Therapeutics, Chelsea, MA, US
- Civitas Therapeutics, Chelsea, MA, US
- Civitas Therapeutics, Chelsea, MA, US
Prosecution history
- 15 Jan 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Apr 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Apr 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 11 Apr 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 11 Apr 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Sept 2022 — TEAS SECTION 8 & 9 RECEIVED
- 02 Dec 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Dec 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Oct 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 Oct 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Oct 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Oct 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL